GRAL

GRAIL INC

GRAL·384747101·US·Common Stock·Healthcare - Diagnostics & Research-13D/G

GRAL (GRAIL INC) is held by 160 institutional investors as of Q2 2026. Largest holders: FARALLON CAPITAL MANAGEMENT, L.L.C. ($284.1M), BAKER BROS. ADVISORS LP ($275M), BlackRock, Inc. ($244.2M). Net institutional sentiment: Mixed.

160
Holders
(14 Elite)
$2B
Total Value
59% (164)
Consensus
97 buying - 67 selling
13F: Insider & Congress: Updated regularly
GRAL

Smart Money Verdict

View all
Loading verdict
Held by 160 funds
14 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Apr 9, 2026 · Activists Aug 13, 2026 · Congress none

ActivistFarallon Capital Management, L.L.C.Farallon Capital Management, L.L.C.9.6%Aug 13, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.6%Aug 7, 2026
ActivistPRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/5.1%Aug 6, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.2M(+27.9%)$284.1M1.3%+23.19%
61
Unchanged
4M$275M1.4%+86.70%
0
Increased
3.6M(+20.5%)$244.2M0.0%+73.35%
37
Increased
2.4M(+26.1%)$162.9M0.0%+76.37%
37
Increased
2.2M(+18.2%)$148.8M0.1%+238.16%
36
Increased
1.6M(+7.5%)$112M0.0%+47.83%
32
Decreased
1.5M(-10.4%)$99.8M0.0%+40.58%
0
Increased
991,380(+19.7%)$67.7M0.0%+100.69%
35
Increased
748,015(+28.5%)$51.1M0.0%+23.24%
37
Decreased
723,437(-20.9%)$49.4M0.0%+26.47%
0
Increased
679,587(+66.3%)$46.4M0.0%+23.35%
43
Increased
477,982(+42.7%)$32.6M0.0%+38.65%
39
Increased
372,588(+6.7%)$25.4M0.0%+118.32%
31
Increased
371,253(+22.9%)$25.3M0.0%+49.35%
35
Increased
300,628(+11.4%)$20.5M0.0%+43.08%
32
Increased
292,829(+0.2%)$20M0.0%+52.63%
28
Increased
249,796(+34.7%)$17.1M0.0%+67.90%
37
Increased
229,503(+5.5%)$15.7M0.0%+101.83%
30
Increased
224,950(+11.8%)$15.4M0.0%+46.32%
31
Decreased
211,341(-27.6%)$14.2M0.0%+293.04%
0

Showing 1-20 of 172

1 / 9
GRALGRALGRAIL INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used